• Introduction Focused ultrasound FUS sonication in the presen

  2019-06-14

  

  Introduction Focused ultrasound (FUS) sonication in the presence of microbubbles (MB) can disrupt the BBB, increasing its permeability. This type of disruption is transient and reversible, and does not damage neural cells. The oscillation and destruction of microbubbles as well as microstreaming an

• We moreover confirmed previous evidence of a net increase

  2019-06-14

  

  We, moreover, confirmed previous evidence of a net increase of CT density of bone metastases after ZA treatment and demonstrated that the changes persist at a 24 months follow-up. This study and previous reports [24–26] have demonstrated significant sclerotic changes of BMs, more evident in patients

• Early repolarization ER is characterized by elevation

  2019-06-14

  

  Early repolarization (ER) is characterized by elevation of the QRS-ST junction (J point) and QRS notching or slurring (J wave) in multiple leads, especially the inferior and/or left precordial leads. Although this finding has been considered to be a benign ECG manifestation, Haïssaguerre et al repor

• Buturovic and Ignatovic rightly point

  2019-06-14

  

  Buturovic and Ignatovic rightly point out that present-day formula is different from the type of milk received by Brazilian infants born in the early 1980s, particularly because long-chain polyunsaturated fatty acids have been added to modern products. Nevertheless, modern biology is constantly unco

• Patient a year old man

  2019-06-14

  

  Patient 2, a 54-year-old man with RAEB 2, and severe chronic obstructive pulmonary disease, struggled through induction chemotherapy with daunorubicin plus cytarabine (DA) 3+10. Second DA 3+8 produced delayed hematopoietic recovery. CR1 was documented after course 1 and lasted 18 months. Relapse was

• br We sincerely appreciate the comment by Lombardi et

  2019-06-13

  

  We sincerely appreciate the comment by Lombardi et al on our published paper. demonstrates the incidence of dyspnea and the discontinuation of ticagrelor due to dyspnea in patients who reported dyspnea in Phase 3/4 clinical trials of acute coronary syndrome with available relevant data. Our study

• nadph oxidase inhibitor In addition evidence of similar

  2019-06-13

  

  In addition, evidence of similar resting HR׳s before exercise in the patients and in the controls implies similar autonomic activity at rest during the daytime in both groups of subjects. In contrast, previous studies have reported changes in the nocturnal HR of BrS patients [3,28]. The discrepancy

• Commission on Global Surgery s vision is universal access

  2019-06-13

  

  Commission on Global Surgery\'s vision is “universal access to safe, affordable surgical and anaesthesia care when needed”. 5 billion people, largely the poor, marginalised, and rural, face impossible hurdles and for all practical purposes are excluded from what is often life-saving or disability-av

• br INTRODUCCI N La historia pol tica

  2019-06-13

  

  INTRODUCCIÓN La historia política de Colombia se ha desarrollado en una tensión permanente. Como lo plantea Cárdenas, esta tensión siempre ha surgido entre la guerra y la búsqueda de la paz. Según el autor: “desde el mismo origen del Estado colombiano, la violencia y los conflictos han sido un el

• Evidence of a variant induction of apoptosis to

  2019-06-13

  

  Evidence of a variant induction of apoptosis to vorinostat in different DLBCL cell lines according to HAT mutational status implies that defects in CREBBP/EP300 could potentially explain the heterogeneous observations in clinical trials of vorinostat in NHL. These findings, however, need to be confi

• In recent years there has been growing interest

  2019-06-13

  

  In recent years, there has been growing interest regarding the role of spliceosome machinery in neoplastic diseases following evidence of the involvement of splicing factor mutations in diverse cancers . (Serine-Arginine Splicing Factor 2) is a member of the serine/arginine (S/A) rich family pre-mR

• Methods We extracted data from the WHO Health Expenditure

  2019-06-13

  

  Methods We extracted data from the WHO Health Expenditure Observatory and the Institute for Health Metrics and Evaluation\'s Financing Global Health 2015 report. We then adjusted these data by converting to a common, inflation-adjusted currency, and completed the series using multiple imputation. We

• In addition further study is required to evaluate whether

  2019-06-12

  

  In addition, further study is required to evaluate whether identified mutations influence post-translational modifications because they are important mechanism of transcription factors for regulating normal and leukemic hematopoiesis. Authors\' contributions Conflict of interest Acknowledgm

• The patient began CODOX M IVAC with rituximab PET

  2019-06-12

  

  The patient began CODOX-M/IVAC with rituximab [2]. PET and BM after 2 cycles showed complete remission (CR) and this was confirmed 3 and 6 months later after he completed the full treatment course. There was no delay in administration of each cycle (average: 19 days, 16–21). Eight months after thera

• Findings Three factors were significant predictors

  2019-06-12

  

  Findings Three factors were significant predictors of treatment failure: the presence of at least 1 month of fair or poor adherence (OR 15·7, 95% CI 1·8–136·7; p=0·01); previous treatment at another clinic before the WWO/AHF Family Health Clinic (1·4, 1·2–13·7; p=0·02); and tuberculosis symptoms at

8896 records 545/594 page Previous Next First page 上5页 541542543544545 下5页 Last page